Avantax Advisory Services’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.06M Sell
21,229
-100
-0.5% -$4.52K 0.01% 1135
2025
Q1
$630K Sell
21,329
-5,127
-19% -$190K ﹤0.01% 1365
2024
Q4
$640K Buy
26,456
+14,053
+113% +$348K ﹤0.01% 1301
2024
Q3
$228K Sell
12,403
-6,148
-33% -$110K ﹤0.01% 1936
2024
Q2
$375K Buy
18,551
+8,440
+83% +$140K ﹤0.01% 1554
2024
Q1
$156K Buy
+10,111
New +$114K ﹤0.01% 1565

Other funds holding HIMS

Avantax Advisory Services's HIMS Position: Q2 2025 in Review

Avantax Advisory Services reduced its Hims & Hers Health (HIMS) stake by 0.47% in Q2 2025, selling an estimated $4.52K and leaving 21,229 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #1135.

Avantax Advisory Services first reported a position in HIMS in Q1 2024 and has held it in 6 quarters since. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

  • Avantax Advisory Services held 21,229 shares of Hims & Hers Health worth $1.06M as of Q2 2025.
  • Avantax Advisory Services sold 100 Hims & Hers Health shares in Q2 2025, an estimated $4.52K.
  • Hims & Hers Health made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1135 holding.
  • Avantax Advisory Services first reported a position in Hims & Hers Health in Q1 2024 and has held it in 6 quarters since.
  • 510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.